Synergy Pharma (SGYP) May be Potential Target for Takeda - Bloomberg, Citing Citi

September 14, 2016 9:36 AM EDT
Get Alerts SGYP Hot Sheet
Price: $5.30 +3.72%

Rating Summary:
    11 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade SGYP Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Synergy Pharma (NASDAQ: SGYP) May be Potential Target for Takeda - Bloomberg, Citing Citi



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Momentum Movers, Rumors, Trader Talk

Related Entities

Citi

Add Your Comment